Drug Trial Radar · NCT05153239
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
705
Actual
Start
Jul 22, 2022
Primary completion
Apr 10, 2026
Study completion Apr 10, 2026
Sponsor
- Lead sponsor
- PharmaMarIndustry
- Sponsor type
- Industry
- First posted
- Dec 10, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter, open-label, randomized, controlled phase III clinical trial to evaluate and compare the activity and safety of two experimental arms consisting of lurbinectedin as single agent (Group A) or the combination of lurbinectedin with irinotecan (Group B) versus Investigator's Choice (topotecan or irinotecan) as control arm (Group C), in Small-cell Lung Cancer (SCLC) patients who failed one prior platinum-containing line.
Conditions
- Relapsed Small Cell Lung Cancer
Interventions
IrinotecanDrug
Irinotecan 75 mg/m² intravenously Days 1 \& 8 q3wk
LurbinectedinDrug
Lurbinectedin 3.2 mg/m² will be administered intravenously on Day 1 q3wk
IrinotecanDrug
For patients aged \<70 years: irinotecan 350 mg/m² intravenously Day 1 q3wk For patients aged ≥70 years: irinotecan 300 mg/m² intravenously Day 1 q3wk
TopotecanDrug
Topotecan 2.3 mg/m² oral or 1.5 mg/m² intravenously Days 1-5 q3wk
LurbinectedinDrug
Lurbinectedin 2.0 mg/m² will be administered intravenously on Day 1 q3wk
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survivalTime frame: From the date of randomization to the date of death or last contact, up to 39 months
Locations
210 sites in 24 countries. Site status is shown where the registry gives one.
Ironwood Cancer & Research Centers
Chandler, Arizona
Genesis Cancer and Blood
Hot Springs, Arkansas
Florida Cancer Specialists - South
Fort Myers, Florida
Florida Cancer Specialists - North
St. Petersburg, Florida
Florida Cancer Specialists - Panhandle
Tallahassee, Florida
Florida Cancer Specialists - East
West Palm Beach, Florida
Duly Health and Care
Joliet, Illinois
Norton Cancer Institue, Downtown
Louisville, Kentucky
Dana-Farber Cancer Institute
Boston, Massachusetts
Oncology Hematology West, PC (Grand Island)
Grand Island, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists
Omaha, Nebraska
FirstHealth Outpatient Cancer Center
Pinehurst, North Carolina
Utah Cancer Specialists
Salt Lake City, Utah
MultiCare Regional Cancer Center - Tacoma
Tacoma, Washington
Froedtert Hospital/Medical College of Wisconsin
Milwaukee, Wisconsin
Northern Beaches Hospital
Frenchs Forest, Australia
Gosford Hospital GH - Central Coast Cancer Centre
Gosford, Australia
Austin Hospital- Medical Oncology Unit
Heidelberg, Australia
St John of God Murdoch Hospital
Murdoch, Australia
Cancer Care Wollongong
Wollongong, Australia
The Chris Obrien Lifehouse
Camperdown, New South Wales, Australia
BRICC - Ballarat Health Services
Ballarat Central, Victoria, Australia
Box Hill Hospital Eastern Health Clinical School
Box Hill, Victoria, Australia
University Hospital Salzburg
Salzburg, Austria
Medizinische Universitaet Wien
Vienna, Austria
Algemeen Ziekenhuis AZ Klina - Borstkliniek
Brasschaat, Belgium
Grand Hopital de Charleroi GHdC - Hopital Saint Joseph
Charleroi, Belgium
Centre Hospitalier Chretien CHC - MontLegia
Liège, Belgium
CHR de la Citadelle
Liège, Belgium
CHU Liege
Liège, Belgium
Az Sint Maarten Mechelen
Mechelen, Belgium
Centre Hospitalier Universitaire (CHU) Ambroise Pare
Mons, Belgium
Antwerp University Hospital
Edegem, Antwerp, Belgium
Fundacao Pio XII - Hospital de Cancer de Barretos - Hospital de Amor
Barretos, Brazil
ONCOSITE - Centro de Pesquisa Clinica em Oncologia Ltda
Ijuí, Brazil
Instituto Nacional de Cancer - Ministrio da Sade
Rio de Janeiro, Brazil
Oncocentro-Centro de Oncologia do Parana
Curitiba, Paraná, Brazil
Irmandade daSanta Casa de Misericordia de Porto Alegre
Porto Alegre, Porto Alegre, Brazil
Hospital Sao Lucas da PUCRS
Porto Alegre, Porto Alegre, Brazil
UPCO - Hospital de Clinicas de Porto Alegre
Santa Cecília, Porto Alegre, Brazil
Showing 40 of 210 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.